Outcome of SARS-CoV-2 and immune thrombocytopenia in a pediatric patient

The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 – A systematic review of the literature

“…The reported cases of ITP associated with SARS-CoV-2 infection are listed in Table 2 with a limited number of cases occurring at pediatric ages [ [22] , [23] , [24] , [25] ]. Of note, an association between low platelet counts (for any cause) and mortality has been found in these cases [ 26 , 27 ].…”

Severe Thrombocytopenic Purpura Associated with COVID-19 in a Pediatric Patient

“… 38 Soares et al reported the case of a 2-year-old patient who developed thrombocytopenia at two different times: during the acute infection and later, ITP, with complete response to IVIG as opposed to our patient who developed ITP in the first week since symptoms’ onset. 39 According to Chen et al, thrombocytopenia in the late stage of the disease, 14 days after the onset of symptoms, is less frequent (11.8%) and significantly associated with higher mortality rate. 40 …”

Severe immune thrombocytopenia that developed immediately after COVID-19 in a school-aged patient: A case report

“…To date, 13 pediatric cases of ITP secondary to COVID-19 have been reported ( Table 1 ) ( 6 – 17 ). Among them, only one patient had developed ITP at almost the same time as the onset of COVID-19 (Case 1 in Table 1 ) ( 6 ).…”

“…To date, 13 pediatric cases of ITP secondary to COVID-19 have been reported ( Table 1 ) ( 6 – 17 ). Among them, only one patient had developed ITP at almost the same time as the onset of COVID-19 (Case 1 in Table 1 ) ( 6 ). Furthermore, the patient developed ITP associated with COVID-19 twice, once on the day of the onset of COVID-19 (day 1) and again on day 25.…”